Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients

L. Mureebe; R.D. Coats; W.R. Silliman

doi:10.1016/J.JVS.2004.12.019

Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients

L. Mureebe
, R.D. Coats
, W.R. Silliman

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Vascular Surgery
Volume	41
Issue number	3
DOIs	https://doi.org/10.1016/J.JVS.2004.12.019
State	Published - Mar 1 2005

Disciplines

Medicine and Health Sciences
Internal Medicine

Access to Document

10.1016/J.JVS.2004.12.019License: Unspecified

Cite this

@article{dc30bd5dc9db474aaf9a1b907d27d776,

title = "Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients",

author = "L. Mureebe and R.D. Coats and W.R. Silliman",

note = "Conclusion: Morbidity and mortality are elevated in hemodialysis patients with heparin-associated antiplatelet antibodies (HAAb). Dialysis patients with HAAb should be considered for alternative anticoagulation during hemodialysis. Summary: Patients on hemodialysis are frequently exposed to heparin. Patient groups with frequent heparin exposure develop HAAb at a high rate.",

year = "2005",

month = mar,

day = "1",

doi = "10.1016/J.JVS.2004.12.019",

language = "American English",

volume = "41",

journal = "Journal of Vascular Surgery",

number = "3",

}

TY - JOUR

T1 - Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients

AU - Mureebe, L.

AU - Coats, R.D.

AU - Silliman, W.R.

N1 - Conclusion: Morbidity and mortality are elevated in hemodialysis patients with heparin-associated antiplatelet antibodies (HAAb). Dialysis patients with HAAb should be considered for alternative anticoagulation during hemodialysis. Summary: Patients on hemodialysis are frequently exposed to heparin. Patient groups with frequent heparin exposure develop HAAb at a high rate.

PY - 2005/3/1

Y1 - 2005/3/1

UR - https://www.jvascsurg.org/article/S0741-5214(04)01659-3/fulltext

U2 - 10.1016/J.JVS.2004.12.019

DO - 10.1016/J.JVS.2004.12.019

M3 - Article

VL - 41

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

IS - 3

ER -

Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients

Disciplines

Access to Document

Other files and links

Cite this